rs121908429
Variant summary
Our verdict is Likely pathogenic. Variant got 8 ACMG points: 8P and 0B. PM5PP2PP3_StrongPP5
The NM_001365088.1(SLC12A6):c.619C>T(p.Arg207Cys) variant causes a missense change. The variant allele was found at a frequency of 0.00000559 in 1,609,900 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 12/21 in silico tools predict a damaging outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R207H) has been classified as Pathogenic.
Frequency
Consequence
NM_001365088.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 8 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A6 | NM_001365088.1 | c.619C>T | p.Arg207Cys | missense_variant | 6/26 | ENST00000354181.8 | NP_001352017.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A6 | ENST00000354181.8 | c.619C>T | p.Arg207Cys | missense_variant | 6/26 | 1 | NM_001365088.1 | ENSP00000346112 | A1 | |
ENST00000559867.1 | n.268G>A | non_coding_transcript_exon_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 152050Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000796 AC: 2AN: 251302Hom.: 0 AF XY: 0.00000736 AC XY: 1AN XY: 135842
GnomAD4 exome AF: 0.00000549 AC: 8AN: 1457850Hom.: 0 Cov.: 28 AF XY: 0.00000551 AC XY: 4AN XY: 725558
GnomAD4 genome AF: 0.00000658 AC: 1AN: 152050Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74266
ClinVar
Submissions by phenotype
Agenesis of the corpus callosum with peripheral neuropathy Pathogenic:5
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 12, 2011 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Jul 15, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2023 | - - |
Pathogenic, no assertion criteria provided | clinical testing | Center for Molecular Medicine, Children’s Hospital of Fudan University | Feb 08, 2022 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Dec 10, 2021 | The SLC12A6 c.619C>T (p.Arg207Cys) missense variant results in the substitution of arginine at amino acid position 207 with cysteine. This variant has been reported in a homozygous state in one individual presenting with complete agenesis of the corpus callosum, demyelinating neuropathy, dysmorphism and psychomotor retardation (Uyanik et al. 2006). This variant is reported in the Genome Aggregation Database in one allele at a frequency of 0.000054 in the East Asian population (version 2.1.1). A different missense change at the same position, c.620G>A (p.Arg207His), has been noted in two individuals affected with early-onset progressive sensorimotor neuropathy in a heterozygous state and of de novo origin (Park et al. 2020). The Arg207Cys variant protein when expressed in Xenopus oocytes showed significantly reduced K+ influx compared to wild-type, suggestive of impaired potassium-chloride transport (Salin-Cantegrel et al. 2011; Park et al. 2020). Further, the Arg207Cys protein was mislocalized to the perinucleus instead of the plasma membrane in HeLa and PC12 cells (Salin-Cantegrel et al. 2011). Based on the available evidence, the c.619C>T (p.Arg207Cys) variant is classified as likely pathogenic for agenesis of the corpus callosum with peripheral neuropathy. - |
Charcot-Marie-Tooth disease Uncertain:1
Uncertain significance, no assertion criteria provided | literature only | Inherited Neuropathy Consortium | - | - - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Aug 23, 2022 | This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 207 of the SLC12A6 protein (p.Arg207Cys). This variant is present in population databases (rs121908429, gnomAD 0.006%). This missense change has been observed in individual(s) with agenesis of the corpus callosum with peripheral neuropathy (PMID: 16606917). ClinVar contains an entry for this variant (Variation ID: 5331). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SLC12A6 protein function. Experimental studies have shown that this missense change affects SLC12A6 function (PMID: 21628467). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at